IL134521A - Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives - Google Patents

Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives

Info

Publication number
IL134521A
IL134521A IL13452198A IL13452198A IL134521A IL 134521 A IL134521 A IL 134521A IL 13452198 A IL13452198 A IL 13452198A IL 13452198 A IL13452198 A IL 13452198A IL 134521 A IL134521 A IL 134521A
Authority
IL
Israel
Prior art keywords
fexofenadine
bioavailability
enhancing
derivatives
pharmaceutical composition
Prior art date
Application number
IL13452198A
Other languages
English (en)
Other versions
IL134521A0 (en
Inventor
Kin-Kai Hwang
Dennis Giesing
Gail H Hurst
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL134521A0 publication Critical patent/IL134521A0/xx
Publication of IL134521A publication Critical patent/IL134521A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL13452198A 1997-08-14 1998-07-21 Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives IL134521A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14
PCT/US1998/015098 WO1999008690A1 (en) 1997-08-14 1998-07-21 Method of enhancing bioavailability of fexofenadine and its derivatives

Publications (2)

Publication Number Publication Date
IL134521A0 IL134521A0 (en) 2001-04-30
IL134521A true IL134521A (en) 2005-07-25

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13452198A IL134521A (en) 1997-08-14 1998-07-21 Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives

Country Status (30)

Country Link
EP (1) EP1003528B1 (pt)
JP (1) JP4295913B2 (pt)
KR (1) KR100522985B1 (pt)
CN (1) CN1143680C (pt)
AR (1) AR018505A1 (pt)
AT (1) ATE224721T1 (pt)
AU (1) AU725965C (pt)
BR (1) BR9811937A (pt)
CA (1) CA2301267C (pt)
CZ (1) CZ293666B6 (pt)
DE (1) DE69808303T2 (pt)
DK (1) DK1003528T3 (pt)
EE (1) EE04263B1 (pt)
ES (1) ES2179523T3 (pt)
HK (1) HK1025901A1 (pt)
HU (1) HU226823B1 (pt)
ID (1) ID24463A (pt)
IL (1) IL134521A (pt)
NO (1) NO325148B1 (pt)
NZ (1) NZ502133A (pt)
OA (1) OA11287A (pt)
PL (1) PL191607B1 (pt)
PT (1) PT1003528E (pt)
RU (1) RU2197967C2 (pt)
SK (1) SK283868B6 (pt)
TR (1) TR200000419T2 (pt)
TW (1) TWI240633B (pt)
UA (1) UA64765C2 (pt)
WO (1) WO1999008690A1 (pt)
ZA (1) ZA987221B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100405116B1 (ko) 1995-02-28 2004-02-05 아벤티스 파마슈티칼스 인크. 피페리디노알칸올화합물에대한약제학적조성물
SI0998272T1 (en) * 1997-08-26 2003-12-31 Aventis Pharmaceuticals Inc. Pharmaceutical composition for combination of piperidinoalkanol-decongestant
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
WO2003101437A2 (en) * 2002-05-29 2003-12-11 Aventis Pharmaceuticals Holdings Inc. Method of treating asthma using fexofenadine
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
EP2709600A1 (en) 2011-05-20 2014-03-26 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising fexofenadine
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
AU5893796A (en) * 1995-06-07 1996-12-30 Novo Nordisk A/S Modification of polypeptides
JPH11507356A (ja) * 1995-06-07 1999-06-29 アブマックス，インコーポレイティド 経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用

Also Published As

Publication number Publication date
EE200000069A (et) 2000-10-16
AU725965C (en) 2004-04-22
HUP0003189A2 (en) 2001-03-28
EE04263B1 (et) 2004-04-15
WO1999008690A1 (en) 1999-02-25
CN1267221A (zh) 2000-09-20
JP4295913B2 (ja) 2009-07-15
HU226823B1 (hu) 2009-11-30
NO20000706D0 (no) 2000-02-11
JP2001515041A (ja) 2001-09-18
PL191607B1 (pl) 2006-06-30
TWI240633B (en) 2005-10-01
NO325148B1 (no) 2008-02-11
AU725965B2 (en) 2000-10-26
EP1003528B1 (en) 2002-09-25
ZA987221B (en) 1999-02-15
TR200000419T2 (tr) 2000-09-21
PL338579A1 (en) 2000-11-06
DK1003528T3 (da) 2003-02-03
CN1143680C (zh) 2004-03-31
PT1003528E (pt) 2003-02-28
SK283868B6 (sk) 2004-03-02
NZ502133A (en) 2002-03-28
CA2301267A1 (en) 1999-02-25
CA2301267C (en) 2004-07-13
ID24463A (id) 2000-07-20
KR20010022845A (ko) 2001-03-26
DE69808303T2 (de) 2003-05-22
SK1842000A3 (en) 2000-08-14
HK1025901A1 (en) 2000-12-01
KR100522985B1 (ko) 2005-10-21
ES2179523T3 (es) 2003-01-16
OA11287A (en) 2003-10-22
CZ293666B6 (cs) 2004-06-16
CZ2000522A3 (cs) 2000-09-13
IL134521A0 (en) 2001-04-30
UA64765C2 (uk) 2004-03-15
AU8505098A (en) 1999-03-08
AR018505A1 (es) 2001-11-28
BR9811937A (pt) 2000-09-05
DE69808303D1 (de) 2002-10-31
EP1003528A1 (en) 2000-05-31
ATE224721T1 (de) 2002-10-15
HUP0003189A3 (en) 2001-04-28
NO20000706L (no) 2000-04-13
RU2197967C2 (ru) 2003-02-10

Similar Documents

Publication Publication Date Title
HUP0002183A3 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
ZA9810490B (en) 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
IL128484A0 (en) Pharmaceutical aerosol composition
HUP0003362A3 (en) Piperidine derivatives and pharmaceutical compositions containing them
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
GB9706089D0 (en) Pharmaceutical composition
HUP0000979A3 (en) Pharmaceutical compositions containing fk-506 and derivatives thereof
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
IL134521A (en) Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0003398A3 (en) Novel triptolide derivatives and pharmaceutical compositions thereof
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
EP0996441A4 (en) PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES
GB9709739D0 (en) Pharmaceutical formulation
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
HUP9902470A3 (en) Biphenylsulfonylamino alkylcarboxylic acid derivatives and pharmaceutical compositions containing them
HUP0003827A3 (en) Cyanoamidine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB20 Patent renewed for 20 years
EXP Patent expired